Nanotechnology safety issues were a hot topic at the NanoBusiness 2005 conference in New York this week. Discussion of the FDA approval process figured prominently in a panel discussion on...
Talk to Lux Research now and learn the benefits of becoming a member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 (0) 20-3460840
For APAC (Singapore)